A single infusion of zoledronic acid 5 mg is significantly more effective than daily oral risedronate 5 mg in increasing bone mineral density of the lumbar spine, hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis - 2008
Paper published in a journal (Scientific congresses and symposiums)
A single infusion of zoledronic acid 5 mg is significantly more effective than daily oral risedronate 5 mg in increasing bone mineral density of the lumbar spine, hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis
Reid, D. M.; Devogelaer, Jean-Pierre; Saag, K.et al.
2008 • In Annals of the Rheumatic Diseases, 67 (Suppl.II), p. 56
General & internal medicine Rheumatology Public health, health care sciences & services
Author, co-author :
Reid, D. M.
Devogelaer, Jean-Pierre
Saag, K.
Roux, Christian
Lau, C.
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Papanastasiou, P.
Ferreira, A.
Hartl, F.
Fashola, T.
Mesenbrink, P.
Sambrook, P.
Language :
English
Title :
A single infusion of zoledronic acid 5 mg is significantly more effective than daily oral risedronate 5 mg in increasing bone mineral density of the lumbar spine, hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis
Publication date :
June 2008
Event name :
Congress of the European League Against Rheumatism (EULAR 2008)
